Overview

Cycloserine rTMS Plasticity Augmentation

Status:
Completed
Trial end date:
2018-11-07
Target enrollment:
Participant gender:
Summary
Transcranial magnetic stimulation (rTMS) is an investigational and therapeutic modality that impacts the connection strength between neurons by delivering patterned energy. In response to this patterned energy neurons fire and adapt by changing their connection strengths. This change in connection strengths is believed to be the underlying mechanism whereby this intervention has therapeutic benefit for this intervention in conditions such as depression. The purpose of this study is to test a means of enhancing the effect of rTMS using a medication (cycloserine) that has been shown to augment and stabilize activity dependent neuronal changes. The investigators wish to use the motor system, where the associated muscle response to brain stimulation can be measured, to probe activity dependent changes in connection strength between neurons.
Phase:
Phase 1
Details
Lead Sponsor:
University of Calgary
Treatments:
Cycloserine